Antibody testing, FIND OUT
I received this information package I wanted to share with you all. I have been blessed to have had the chance to work with, learn from, and get to know too many amazing Doctors and Scientists to count. This gives me the chance to be the tip of the spear so to speak on sharing new developments in this World Scamdemic. This is one of those times courtesy of Dr Pelech.
Dr Steven Pelech
It is great to hear from you, and I am so grateful for everything you have done for the CCCA and informing Canadians about COVID-19. Please forgive me for my delayed response to your original e-mail about getting the SARS-CoV-2 antibody test. I have been absolutely deluged with e-mails and phone calls, and it has been a struggle to keep up.
The latest test that we are now using has 41 markers from 10 of the SARS-CoV-2 proteins, including many for its spike protein. These 41 markers, corresponding to small portions of the SARS-CoV-2 viral proteins, were carefully selected from an initial screen of over 8000 potential markers from this coronavirus using serum samples from over 20 recovered COVID-19 patients that were confirmed by PCR testing. Since then we have analyzed blood samples from over 100 recovered COVID-19 survivors and over 600 other people. We have found clear evidence of SARS-CoV-2 protein-specific antibodies in serum samples from COVID-19 patients even over 15 months since their initial infection.
We believe that our SARS-CoV-2 antibody screening is more sensitive and with higher selectivity than any competing tests. It has not yet been approved by Health Canada for use as a test of SARS-CoV-2 immunity. Therefore, we can only offer it FOR RESEARCH PURPOSES ONLY, and enroll you in a formalized clinical trial with Independent Review Board (Veritas IRB) approval that we have been performing. It may be possible that a positive result with our test may be sufficient to show proof of immunity in some venues. We can provide letters for confirmation of enrolment in our clinical trial upon request. However, we cannot provide medical exception letters for mandatory vaccination, although the information on your immune status might be useful for your physician to provide you with one.
As we have not received any external funding to support this clinical trial, we have to offer the testing on a cost recovery basis. The cost of the 41 marker test, including the sampling of your blood with a lancet prick of your finger is $50 plus applicable taxes. Payment can be by e-transfer (e.g., Interac-transfer), or check.
Since you live outside of the Vancouver area where Kinexus is located, our new dried blood spot test for SARS-CoV-2 antibodies in the blood samples would be the most suitable for you. We are now finally starting to taking requests for this test. We will be charging an extra $15 plus shipping costs and applicable taxes for a blood drop sampling kit that we would mail out to you. You would add a few drops of your blood to the sampling membrane card with the lancets that we provide, and then send it back to Kinexus by rapid post or courier. We would then perform a 41-marker test for detection of antibodies against 10 of the SARS-CoV-2 proteins.
The attached Ordering Form specifies how many blood sample kits you will need with subsequent testing of the dried blood drop samples. The actual testing will involve examination of 41 of the best markers for parts of 10 different SARS-CoV-2 proteins that we have found to be the most common amongst recovered COVID-19 patients for eliciting antibody production. The attached Inform Consent Form enrols you into our clinical trial, so that we can publish the aggregate results of our study in peer-reviewed scientific journals to alert the biomedical research community about our findings. You may find it helpful to be officially involved in our trial to possibly provide you with a reason for why you may not want to be vaccinated. The attached Blood Sampling Kit Instructions explains how to go about collecting the necessary blood drops for permitting us to determine the level and type of antibody immunoreactivity that you have. Due to high demand, we are projecting at least a two week turnaround after we receive your blood samples. However, for you I will personally try to expedite this.
You may make copies of these forms for your family and close associates to use. Each kit is for one person, and a separate Informed Consent Form must be completed for each person as this is used to identify blood sample that is received and for e-mail transmission of our findings back to that person. These completed forms should be e-mail to Ms. Catherine Sutter at COVID@kinexus.ca
:) Best wishes and warm regards from Steve.